Financial Summary (All financials)
| In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| Revenues | 100.2 | 104.9 | 91.2 | 82.5 | 77.9 | |
| Revenue growth | -4.5% | 15.0% | 10.6% | 5.9% | | |
| Cost of goods sold | 54.0 | 54.5 | 46.0 | 40.3 | 37.8 | |
| Gross profit | 46.2 | 50.3 | 45.2 | 42.3 | 40.1 | |
| Gross margin | 46.2% | 48.0% | 49.6% | 51.2% | 51.5% | |
| Selling, general and administrative | 28.0 | 28.4 | 33.1 | 22.4 | 22.0 | |
| Research and development | 5.1 | 4.3 | 3.7 | 3.1 | 3.2 | |
| EBIT | 13.4 | 18.0 | 9.0 | 17.2 | 15.8 | |
| EBIT margin | 13.4% | 17.2% | 9.9% | 20.8% | 20.2% | |
| Pre-tax income | 22.9 | 18.1 | 10.2 | 19.4 | 18.2 | |
| Income taxes | -1.1 | -0.9 | -0.6 | -2.0 | -2.6 | |
| Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|